Latest News for: rpe

Edit

Safety evaluation of the food enzyme ribonuclease P from the non‐genetically modified Penicillium citrinum strain AE‐RPE (EFSA - European Food Safety Authority)

Public Technologies 24 Feb 2026
) Safety evaluation of the food enzyme ribonuclease P from the non‐genetically modified Penicillium citrinum strain AE‐RPE ... modified Penicillium citrinum strain AE‐RPE by Amano Enzyme Inc.
Edit

Dust Control: Why RPE Isn’t Enough for Protecting the Workforce (Andrews Sykes Group plc)

Public Technologies 20 Feb 2026
) Respiratory Protective Equipment (RPE) has long been a familiar sight on construction sites ... It is becoming increasingly clear that RPE alone is not enough. [...] ... Disclaimer ... (noodl. 129613743) .
Edit

Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPE

The Times of India 28 Jan 2026
... Phase 2 clinical trials for its Eyecyte-RPE cell therapy.
Edit

Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.

PR Newswire 09 Dec 2025
The CPCB-RPE1 implant, RPT's lead product, is a bio-engineered implant consisting of stem cell-derived, retinal pigmented epithelial (RPE) cells on an ultrathin synthetic parylene membrane.
  • 1

Article Search

tools
×
×
×
×